Alessio De Rose: Addressing Micronutrient Deficiencies in the Era of GLP-1 Receptor Agonists
Alessio De Rose, Nutrition Manager at S.S. Lazio, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Nutrients, adding:
“I am thrilled to share our recently published article in Nutrients:
‘Ironing Out Possible Micronutrient Deficiencies Associated with Incretin Receptor Agonist-Based Therapies: Proposed Practical Strategies to Prevent and Manage Iron Deficiency’
Incretin receptor agonist-based therapies, including GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists, have significantly changed the management of type 2 diabetes, overweight, and obesity.
As their clinical use continues to expand, it is becoming increasingly important to consider not only their metabolic benefits, but also their potential nutritional implications.
In this perspective article, we discuss emerging evidence on the possible association between incretin-based therapies and iron deficiency/iron deficiency anemia, explore the potential underlying mechanisms, and propose practical strategies for prevention, biochemical monitoring, and clinical-nutritional management.
This work highlights the importance of integrating pharmacological innovation with careful nutritional assessment and individualized patient care.
I am grateful to all co-authors and collaborators for their valuable contribution to this work.”
Title: Ironing Out Possible Micronutrient Deficiencies Associated with Incretin Receptor Agonist-Based Therapies: Proposed Practical Strategies to Prevent and Manage Iron Deficiency
Authors: Marco Infante, Camillo Ricordi, Francesca Pacifici, Donatella Pastore, Raffaele Infante, Massimiliano Caprio, Francesca Chiereghin, Alessandro De Stefano, Giulia Frank, Alessio De Rose, Lorenzo Romano, Laura Di Renzo, Valentina Rovella, Antonino De Lorenzo, Giulia Donadel, David Della-Morte

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments